摘要
Acetaminophen (APAP) is the leading cause of acute liver failure (ALF), which is characterized by GSH depletion, oxidative stress and mitochondrial dysfunction. However, the specific mechanism of APAP-induced ALF remains to be clarified. In this study, we demonstrated that indoleamine 2,3-dioxygenase 1 (IDO1) aggravated APAPinduced ALF associated with excess lipid peroxidation, which was reversed by lipid peroxidation inhibitor (ferrostatin-1). Meanwhile, IDO1 deficiency effectively decreased the accumulation of reactive nitrogen species. Additionally, IDO1 deficiency prevented against APAP-induced liver injury through suppressing the activation of macrophages, thereby reduced their iron uptake and export, eventually reduced iron accumulation in hepatocytes through transferrin and transferrin receptor axis. In summary, our study confirmed that APAP-induced IDO1 aggravated ALF by triggering excess oxidative and nitrative stress and iron accumulation in liver. These results offer new insights for the clinical treatment of ALF or iron-dysregulated liver diseases in the future.
学科与关键词
- Indoleamine 2, 3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stressZeng, Ting; Deng, Guanghui; Zhong, Weichao; Gao, Zhuowei; Ma, Shuoyi; Mo, Chan; Li, Yunjia; Huang, Sha; Zhou, Chuying; Lai, Yuqi; Xie, Shuwen; Xie, Zeping; Chen, Yuyao; He, Songqi*; Lv, Zhiping*; Gao, Lei*Free Radical Biology and Medicine, 2020, 152: 668-679.被引 39
- Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injuryRamachandran A; Lebofsky M; Baines C P; Lemasters J J; Jaeschke H*Free Radical Research, 2011, 45(2): 156-164.
- Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure Through Inhibiting GSK3β-Nrf2-Mediated Hepatocyte Apoptosis and FerroptosisHuang, Sha; Wang, Yuhua; Xie, Shunwen; Lai, Yuqi; Mo, Chan; Zeng, Ting; Kuang, Shanshan; Deng, Guanghui; Zhou, Chuying; Chen, Yuyao; Huang, Shaohui; Gao, Lei*; Lv, Zhiping*Cellular and Molecular Gastroenterology and Hepatology, 2022, 13(6): 1649-1672.被引 23
